Increased mortality and disability in Mexican children with maple syrup urine disease (MSUD);Elevada mortalidad y discapacidad en niños mexicanos con enfermedad de orina con olor a jarabe de arce (EOJA)

Gaceta Medica de Mexico

Volumn 143, Issue 3, 2007, Pages 197-201

  Ibarra González, Isabel ^a   Fernández Lainez, Cynthia ^a   Belmont Martínez, Leticia ^a   Vela Amieva, Marcela ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Cognitive impairment; Inborn errors of metabolism; Infantile mortality; Maple syrup urine disease; Neonatal screening

Indexed keywords

BRANCHED CHAIN AMINO ACID;

AMINO ACID BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; COGNITIVE DEFECT; EARLY DIAGNOSIS; EATING HABIT; FEMALE; FOLLOW UP; GENETIC SCREENING; HUMAN; INFANT; INFANT MORTALITY; INTELLIGENCE; MALE; MAPLE SYRUP URINE DISEASE; MEXICO; MUSCLE HYPOTONIA; NEWBORN SCREENING; PHYSICAL CAPACITY; RETROSPECTIVE STUDY; SCREENING TEST; SEIZURE; SURVIVOR; UNITED STATES; CROSS-SECTIONAL STUDY; MORTALITY; NEWBORN; PSYCHOMOTOR DISORDER;

CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MAPLE SYRUP URINE DISEASE; MEXICO; PSYCHOMOTOR DISORDERS; RETROSPECTIVE STUDIES;

EID: 38449084779     PISSN: 00163813     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Garg U, Dasouki M. Expanded newborn screening of inherited metabolic disorders by tandem mass spectrometry: Clinical and laboratory aspects. Clin Biochem 2006;39:315-332.
2. Simon E, Wendel U, Schadewaldt P. Maple syrup urine disease-treatment and outcome in patients of turkish descent in Germany. Turk J Pediatr 2005;47:8-13.
3. Cederbaum S. Phenylketonuria: an update. Curr Opin Pediatr 2002;14:702-706.
4. National Center for Biotechnology Information. OMIM: Online Mendelian Inheritance in Man [database]. Available at: www.ncbi.nlm.nih.gov/entrez/query. fcgi?db_OMIM. Accessed sept 18, 2006.
5. Chuang DT, Shih VE. Maple Syrup Urine Disease (Branched-Chain Ketoaciduria). En: The Metabolic and Molecular Basis of Inherited Disease. Scriver CR, Beaudet AL, Valle D (Eds.) McGraw-Hill Inc., 8a Edición, New York, EUA, 2001, pp 1991-1995.
6. Ogier de Baulny H, Saudubray JM. Branched-Chain Organic Acidurias. En: Inborn Metabolic Diseases Diagnosis and Treatment. Fernandes J, Saudubray JM, Van den Berghe G (Eds.) Springer, 3a Edición, New York, EUA, 2000, pp 197.
7. Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI. Diagnosis and treatment of Maple Syrup Urine Disease: A study of 36 Patients. Pediatrics 2002;109:999-1007.
8. Kaye CI, Committee on Genetics; Accurso F, La Franchi S, Lane PA, Hope N, Sonya P, G Bradley S, Michele A LP. Newborn screening fact sheets. Pediatrics 2006;118:934-963.
9. Deng C, Deng Y. Diagnosis of maple syrup urine disease by determination of L-valine, L-isoleucine, L-leucine and L-phenylalanine in neonatal blood spots by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 792:261-268.
10. Tajima G, Yofune H, Bahagia Febriani AD, Nishimura Y, Ono H, Sakura N. A simple and rapid enzymatic assay for the branched-chain alpha-ketoacid dehydrogenase complex using high performance liquid cromatography. J Inherit Metab Dis 2004;27:633-639.
11. Rogríguez-Pombo P, Navarrete R, Merinero B, Gomez-Puertas P, Ugarte M. Mutational spectrum of maple syrup urine diasease in Spain. Hum Mutat 2006;27:715.
12. Chuang DT, Chuang JL, Wynn RM. Lessons from genetic disorders of branched-chain amino acid metabolism. J Nutr 2006;136(1 Suppl):243S-249S.
13. Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, et al. Elective liver transplantation for the treatment of classical maple syrup urine disease. Am J Transplant 2006;6:557-564.
14. Khanna A, Hart M, Nyhan WL, Hassanein T, Panyard-Davis J, Barshop BA. Domino liver transplantation in maple syrup urine disease. Liver Transpl 2006;12:876-882.
15. Snyderman SE. In response to le Roux et al. J Inherit Metab Dis 2006;29:690.
16. le Roux C, Murphy E, Lilburn M, Lee PJ. The longest-surviving patient with classical maple syrup urine disease. J Inherit Metab Dis. 2006;29:190-194.
17. Norma Oficial Mexicana-007-SSA2-1993. Atención a la mujer durante el embarazo, parto y puerperio y del RN, criterios y procedimientos para la prestación del servicio. Diario Oficial de la Federación Tomo CDXCVI No.5 México, D.F. viernes 6 de enero de 1995.
18. Velázquez A, Vela M, Ciceron I, Ibarra I, Pérez M, Olivares Z, et al. Diagnosis of inborn errors of metabolism. Arch Med Res 2000;31:145-150.
19. Lin JF, Chiu PC, Hsu HY, Lin SM, Chen YY, Hsieh KS. An early diagnosis leads to a good prognosis: a patient with maple syrup urine disease -screened by tandem mass spectrometry. Acta paediatr Taiwán 2004;45:287-289.
20. Heldt K, Schwahn B, Marquardt I, Grotzke M, Wendel U. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Mol Genet Metab 2005;84:313-316.
21. Lloyd-Puryear MA, Tonniges T, van Dyck PC, Mann MY, Brin A, Johnson K, et al. American Academy of Pediatrics Newborn Screening Task Force recommendations: how far have we come? Pediatrics 2006;117:S194-S211.
22. Korein J, Sansaricq C, Kalmijn M, Honig J, Lange B. Maple syrup urine disease: clinical, EEG, and plasma amino acid correlations with a theoretical mechanism of acute neurotoxicity. Int J Neurosci 1994;79:21-45.
23. Riviello JJ Jr, Rezvani I, DiGeorge AM, Foley CM. Cerebral edema causing death in children with maple syrup urine disease. J Pediatr 1991;119:42-45.